# A Multiple Ascending Dose Study of LW402 in Healthy Volunteers

> **NCT07546149** · PHASE1 · COMPLETED · sponsor: **Shanghai Longwood Biopharmaceuticals Co., Ltd.** · enrollment: 36 (actual)

## Conditions studied

- Safety Evaluation of Escalating Doses

## Interventions

- **DRUG:** Experimental
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07546149
- **Lead sponsor:** Shanghai Longwood Biopharmaceuticals Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-10-15
- **Primary completion:** 2025-12-09
- **Final completion:** 2025-12-31
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2026-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07546149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07546149, "A Multiple Ascending Dose Study of LW402 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07546149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*